Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

TTC30B Inhibitors

TTC30B inhibitors are a class of chemical compounds that specifically target and inhibit the function of tetratricopeptide repeat domain 30B (TTC30B), a protein that plays a key role in the maintenance and function of primary cilia. Primary cilia are microtubule-based organelles that extend from the surface of most vertebrate cells and act as signaling hubs for a variety of cellular processes, including sensing environmental cues and mediating signal transduction pathways. TTC30B is involved in the regulation of ciliary assembly and stability, particularly through its role in intraflagellar transport (IFT), a process essential for the movement of molecular cargoes along the ciliary axoneme. By targeting and inhibiting TTC30B, these compounds can disrupt the proper formation or function of cilia, affecting cellular signaling and sensory functions mediated by cilia.

Inhibiting TTC30B offers researchers a way to explore the molecular mechanisms that govern cilia dynamics and their influence on cellular processes. Since TTC30B is crucial for the structural integrity and function of primary cilia, inhibiting it helps elucidate how disruptions in ciliary assembly affect the organization and movement of molecular complexes involved in signaling pathways. By studying the effects of TTC30B inhibition, researchers can also investigate how primary cilia contribute to various cellular activities, such as cell cycle regulation and environmental sensing. Furthermore, TTC30B inhibitors are valuable for understanding the broader role of tetratricopeptide repeat (TPR) proteins, which are involved in protein-protein interactions and are critical for numerous cellular processes. This class of inhibitors provides a tool for dissecting the intricate role of cilia in cellular communication and regulation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wnt-C59

1243243-89-1sc-475634
sc-475634A
sc-475634B
5 mg
10 mg
50 mg
$210.00
$320.00
$1250.00
1
(0)

An inhibitor of Wnt production that can affect Wnt signaling, a pathway that may regulate TTC30B expression or function.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor that can suppress protein synthesis, possibly affecting the levels of TTC30B.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

An inhibitor of TGF-β signaling that can modify cellular differentiation processes, potentially influencing TTC30B activity.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$35.00
$115.00
$515.00
26
(1)

An inhibitor of the Wnt/β-catenin signaling pathway, which can regulate gene expression and may affect TTC30B.

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$94.00
$286.00
27
(1)

An inhibitor of Wnt processing and secretion that can decrease Wnt signaling, potentially affecting TTC30B activity.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$99.00
$335.00
$836.00
$2099.00
47
(3)

An inhibitor of γ-secretase that can alter Notch signaling, a pathway that might intersect with TTC30B's function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that can affect the PI3K/Akt pathway, potentially impacting protein synthesis and TTC30B expression.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor that can affect cytoskeleton organization, potentially influencing the cellular context of TTC30B.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$65.00
$267.00
257
(3)

An inhibitor of JNK, potentially modifying AP-1 transcription factor activity and possibly affecting TTC30B regulation.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

A proteasome inhibitor that can increase protein degradation stress, potentially influencing TTC30B stability.